Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Share-based Payment Arrangement, Expense

2.8 / 5 stars · 68/120 Roast Me

VYOME HOLDINGS, INC. Share-based Payment Arrangement, Expense

VYOME HOLDINGS, INC. (HIND) reported Share-based Payment Arrangement, Expense of $16.75 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-12

  • VYOME HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $11.05K, a 7.91% decline year-over-year.
  • VYOME HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $5.70K.
  • VYOME HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $3.02K, a 79.87% decline year-over-year.
  • VYOME HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $574.11K, a 1694.09% increase year-over-year.
  • VYOME HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2025 was $577.13K, a 213.66% increase from fiscal 2024.
  • VYOME HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2024 was $184.00K, a 75.98% decline from fiscal 2023.
  • VYOME HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2023 was $766.00K, a 63.30% decline from fiscal 2022.
  • VYOME HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2022 was $2.09M, a 82.93% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 3 month as first filedShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 6 month as first filedShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 9 month as first filedShare-based Payment Arrangement, Expense 12 monthShare-based Payment Arrangement, Expense 12 month as first filed
2026-06-30$11.05K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$16.75K
10-Q · filed 2026-08-12
$19.77K
derived: sum of 3 quarters · filed 2026-08-12
$593.88K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$5.70K
10-Q · filed 2026-05-12
$8.71K
derived: sum of 2 quarters · filed 2026-05-12
$582.82K
derived: sum of 3 quarters · filed 2026-05-12
$594.82K
derived: sum of 4 quarters · filed 2026-05-12
2025-12-31$3.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$577.13K
derived: sum of 2 quarters · filed 2026-03-18
$589.13K
derived: sum of 3 quarters · filed 2026-03-18
$577.13K
10-K · filed 2026-03-18
2025-09-30$574.11K
10-Q · filed 2025-11-14
$586.11K
derived: sum of 2 quarters · filed 2025-11-14
$574.11K
10-Q · filed 2025-11-14
$601.11K
derived: sum of 4 quarters · filed 2026-05-12
2025-06-30$12.00K
10-Q · filed 2025-08-14
$0.00
10-Q · filed 2026-08-12
$27.00K
10-Q · filed 2025-08-14
$27.00K
derived: sum of 3 quarters · filed 2026-05-12
$59.00K
derived: sum of 4 quarters · filed 2026-05-12
2025-03-31$0.00
10-Q · filed 2026-05-12
$15.00K
10-Q · filed 2025-05-20
$15.00K
derived: sum of 2 quarters · filed 2026-05-12
$47.00K
derived: sum of 3 quarters · filed 2026-05-12
$112.00K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$15.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04
$47.00K
derived: sum of 2 quarters · filed 2025-04-04
$112.00K
derived: sum of 3 quarters · filed 2025-08-14
$184.00K
10-K · filed 2025-04-04
2024-09-30$32.00K
10-Q · filed 2024-11-14
$97.00K
derived: sum of 2 quarters · filed 2025-08-14
$169.00K
10-Q · filed 2024-11-14
$279.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-06-30$65.00K
10-Q · filed 2025-08-14
$137.00K
10-Q · filed 2025-08-14
$247.00K
derived: sum of 3 quarters · filed 2025-08-14
$463.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$72.00K
10-Q · filed 2025-05-20
$182.00K
derived: sum of 2 quarters · filed 2025-05-20
$398.00K
derived: sum of 3 quarters · filed 2025-05-20
$615.00K
derived: sum of 4 quarters · filed 2025-05-20
2023-12-31$110.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04
$326.00K
derived: sum of 2 quarters · filed 2025-04-04
$543.00K
derived: sum of 3 quarters · filed 2025-04-04
$766.00K
10-K · filed 2025-04-04
$767.00K
10-K · filed 2024-04-01
2023-09-30$216.00K
10-Q · filed 2024-11-14
$433.00K
derived: sum of 2 quarters · filed 2024-11-14
$656.00K
10-Q · filed 2024-11-14
$895.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$217.00K
10-Q · filed 2024-08-14
$440.00K
10-Q · filed 2024-08-14
$679.00K
derived: sum of 3 quarters · filed 2024-08-14
$1.04M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$222.00K
10-Q · filed 2024-05-15
$462.00K
derived: sum of 2 quarters · filed 2024-05-15
$821.00K
derived: sum of 3 quarters · filed 2024-05-15
$1.59M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$240.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$599.00K
derived: sum of 2 quarters · filed 2024-04-01
$1.37M
derived: sum of 3 quarters · filed 2024-04-01
$2.09M
10-K · filed 2024-04-01
2022-09-30$359.00K
10-Q · filed 2023-11-09
$388.00K
10-Q · filed 2022-11-14
$1.13M
derived: sum of 2 quarters · filed 2023-11-09
$1.85M
10-Q · filed 2023-11-09
$1.96M
10-Q · filed 2022-11-14
$3.62M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$770.00K
10-Q · filed 2023-08-07
$823.00K
10-Q · filed 2022-08-19
$1.49M
10-Q · filed 2023-08-07
$1.57M
10-Q · filed 2022-08-19
$3.26M
derived: sum of 3 quarters · filed 2023-08-07
$13.98M
derived: sum of 4 quarters · filed 2023-08-07
2022-03-31$719.00K
10-Q · filed 2023-05-15
$747.00K
10-Q · filed 2022-05-23
$2.49M
derived: sum of 2 quarters · filed 2023-05-15
$13.21M
derived: sum of 3 quarters · filed 2023-05-15
$12.85M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
$12.49M
derived: sum of 2 quarters · filed 2023-04-17
$12.13M
derived: sum of 3 quarters · filed 2023-04-17
$12.23M
10-K · filed 2023-04-17
$12.75M
10-K · filed 2022-04-08
2021-09-30$10.72M
10-Q · filed 2022-11-14
$10.36M
derived: sum of 2 quarters · filed 2022-11-14
$10.46M
10-Q · filed 2022-11-14
$10.75M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$364.00K
10-Q · filed 2022-08-19
-$263.00K
10-Q · filed 2022-08-19
$31.00K
derived: sum of 3 quarters · filed 2022-08-19
$286.00K
derived: sum of 4 quarters · filed 2022-08-19
2021-03-31$101.00K
10-Q · filed 2022-05-23
$395.00K
derived: sum of 2 quarters · filed 2022-05-23
$650.00K
derived: sum of 3 quarters · filed 2022-05-23
$997.00K
derived: sum of 4 quarters · filed 2022-05-23
2020-12-31$294.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08
$549.00K
derived: sum of 2 quarters · filed 2022-04-08
$896.00K
derived: sum of 3 quarters · filed 2022-04-08
$1.32M
10-K · filed 2022-04-08
2020-09-30$255.00K
10-Q · filed 2021-11-12
$602.00K
derived: sum of 2 quarters · filed 2021-11-12
$1.03M
10-Q · filed 2021-11-12
2020-06-30$347.00K
10-Q · filed 2021-08-16
$774.00K
10-Q · filed 2021-08-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36